Prevalence of Extended-spectrum beta-lactamases- producing Escherichia coli and Klebsiella pneumonia from patients attending Tripoli University Hospital, Tripoli, Libya

Dalal A. Thwood; Zaynab A. Elgadiym; Maren F. Hnaya; Amina Abosedra

doi:10.54361/ljmr.v17i2.08

Authors

Dalal A. Thwood Department of Microbiology, Libyan Biotechnology Research Center, Tripoli, Libya Author
Zaynab A. Elgadiym Department of Microbiology, Libyan Biotechnology Research Center, Tripoli, Libya Author
Maren F. Hnaya Department of Microbiology, Tripoli University Hospital, Tripoli, Libya Author
Amina Abosedra Microbiology department, Faculty of Medicine, University of Benghazi, Benghazi, Libya Author

DOI:

https://doi.org/10.54361/ljmr.v17i2.08

Keywords:

K. pneumoniae, E. coli, MDR, ESBLs

Abstract

Prevalence of extended-spectrum β-lactamases (ESBLs)- producing E. coli and K. pneumoniae has been increased globally. The study aimed to detect the prevalence of ESBL-producing E. coli and K. pneumoniae isolated from clinical specimens in Tripoli university hospital (TUH) and to evaluate their antimicrobial resistance profile. We retrospectively reviewed the recorded cultures results in the microbiology laboratory, TUH during the first half of the year 2021. 77% of E. coli and 72.5% K. pneumonia were multidrug resistant. ESBL phenotype detected in 20% of K. pneumonia and 17.5% E. coli. ESBLs were isolated more frequently from the surgical ward (32.4%). ESBLs show high resistance to beta-lactam and other antibiotics including TMP/SMZ, and aminoglycosides. Our study showed a considerably high prevalence of ESBLs positive strains of E. coli and k. pneumoniae

References

Pitout JD, Laupland KB. Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern. The Lancet Infect Dis 2008; 8(3):159-66. DOI: https://doi.org/10.1016/S1473-3099(08)70041-0

World Health Organization (WHO) Scientific Working Group. Antimicrobial resistance. Bulletin of the World Health Organization. 1983;61(3):383.

European Centre for Disease Prevention and Control. Antimicrobial resistance surveillance in Europe 2015. Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). Stockholm: ECDC; 2017.

Ghafourian S, Sadeghifard N, Soheili S, Sekawi Z. Extended spectrum beta-lactamases: definition, classification and epidemiology. Curr Issues Mol Biol. 2015 ;17(1):11-22.

Riccio ME, Verschuuren T, Conzelmann N, Martak D, Meunier A, Salamanca E, et al. Household acquisition and transmission of extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae after hospital discharge of ESBL-positive index patients. Clin Microbiol Infect. 2021; 27(9):1322-29. DOI: https://doi.org/10.1016/j.cmi.2020.12.024

Duval A, Obadia T, Boëlle PY, Fleury E, Herrmann JL, Guillemot D, et al. Close proximity interactions support transmission of ESBL-K. pneumoniae but not ESBL-E. coli in healthcare settings. PLoS Comput Biol.2019;15(5). DOI: https://doi.org/10.1371/journal.pcbi.1006496

Otter JA, Natale A, Batra R, Auguet OT, Dyakova E, Goldenberg SD, et al. Individual-and community-level risk factors for ESBL Enterobacteriaceae colonization identified by universal admission screening in London. Clin Microbiol Infect. 2019;25(10):1259-65. DOI: https://doi.org/10.1016/j.cmi.2019.02.026

Xercavins M, Jiménez E, Padilla E, Riera M, Freixas N, Boix-Palop L, et al. High clonal diversity of ESBL-producing Klebsiella pneumoniae isolates from clinical samples in a non-outbreak situation. A cohort study. Antimicrob Resist Infect Control. 2020; 1:1-9. DOI: https://doi.org/10.1186/s13756-019-0661-9

Mohammed I, Abass E. Phenotypic detection of Extended Spectrum β-Lactamases (ESBL) among gram negative uropathogens reveals highly susceptibility to imipenem. Pak J Med Sci. 2019;35(4):1104. DOI: https://doi.org/10.12669/pjms.35.4.207

Zahar JR, Blot S, Nordmann P, Martischang R, Timsit JF, Harbarth S, et al. Screening for intestinal carriage of extended-spectrum Beta-lactamase–producing Enterobacteriaceae in critically ill patients: expected benefits and evidence-based controversies. Clin Infect Dis. 2019;68(12):2125-30. DOI: https://doi.org/10.1093/cid/ciy864

Murphy D, Ricci A, Auce Z, Beechinor JG, Bergendahl H, Breathnach R, et al. Joint Scientific Opinion on measures to reduce the need to use antimicrobial agents in animal husbandry in the European Union, and the resulting impacts on food safety (RONAFA). EFSA Journal. 2017;15(1): EFSA J. 15:4666. DOI: https://doi.org/10.2903/j.efsa.2017.4666

Falgenhauer L, Imirzalioglu C, Oppong K, Akenten CW, Hogan B, Krumkamp R, et al. Detection and characterization of ESBL-producing Escherichia coli from humans and poultry in Ghana. Front. Microbiol. 2019;9:3358.doi: 10.3389/fmicb.2018.03358. DOI: https://doi.org/10.3389/fmicb.2018.03358

Woerther PL, Andremont A, Kantele A. Travel-acquired ESBL-producing Enterobacteriaceae: impact of colonization at individual and community level. J Travel Med. 2017; 24(suppl_1): S29-34. DOI: https://doi.org/10.1093/jtm/taw101

Arcilla MS, Van Hattem JM, Bootsma MC, van Genderen PJ, Goorhuis A, Grobusch MP, et al Prevalence and risk factors for carriage of ESBL-producing Enterobacteriaceae in a population of Dutch travellers: a cross-sectional study. Travel Med Infect Dis. 2020; 33:101547. DOI: https://doi.org/10.1016/j.tmaid.2019.101547

World Health Organization (WHO). Global Priority List of Antibiotic-Resistant Bacteria to Guide Research, Discovery, and Development of New Antibiotics. 2017.

Jansåker F, Boel JB, Thønnings S, Hertz FB, Hansen KH, Frimodt-Møller N, et al. Pivmecillinam compared to other antimicrobials for community-acquired urinary tract infections with E. coli ESBL-producing or not–a retrospective cohort study. Infect Drug Resist. 2019; 12:1691. DOI: https://doi.org/10.2147/IDR.S209255

Hawkey PM, Warren RE, Livermore DM, McNulty CA, Enoch DA, Otter JA, et al. Treatment of infections caused by multidrug-resistant gram-negative bacteria: Report of the British society for antimicrobial chemotherapy/healthcare infection society/british infection association joint working party. J Antimicrob Chemother. 2018;73(suppl 3): 2-78. DOI: https://doi.org/10.1093/jac/dky027

Paterson DL, Isler B, Harris PN. PRO: Carbapenems should be used for ALL infections caused by ceftriaxone-resistant Enterobacterales. JACAntimicrob Resist. 2021 ;3(1):dlab013. DOI: https://doi.org/10.1093/jacamr/dlab013

Giurazza R, Mazza MC, Andini R, Sansone P, Pace MC, Durante-Mangoni E. Emerging Treatment Options for Multi-Drug-Resistant Bacterial Infections. Life(Basel).2021;3;11(6):519.doi: 10.3390/life11060519. PMID: 34204961; PMCID: PMC8229628. DOI: https://doi.org/10.3390/life11060519

Zohar I, Schwartz O, Yossepowitch O, David SS, Maor Y. Aminoglycoside versus carbapenem or piperacillin/tazobactam treatment for bloodstream infections of urinary source caused by Gram-negative ESBL-producing Enterobacteriaceae. J Antimicrob Chemother. 2020;75(2):458-65. DOI: https://doi.org/10.1093/jac/dkz457

Altayar MA, Thokar MA, Mohammad A. Extended-spectrum B-lactamase Producing E.coli in Clinical Isolates In Benghazi, Libya: Phenotypic Detection and Antimicrobial susceptibility Pattern. Med J Islam World Acad Sci. 2012;20(2):49–56.

Zorgani A, Almagatef A, Sufya N, Bashein A, Tubbal A. Detection of CTX-M-15 among uropathogenic Escherichia coli isolated from five major hospitals in Tripoli, Libya. Oman Med J. 2017;32(4):322. DOI: https://doi.org/10.5001/omj.2017.61

Taher I,Shahlol1 AM, Abukhres OM. Prevalence and characterization of Extended-Spectrum β -Lactamase- producing enterobacteriaceae in Brack-Alshati, Fezzan, Libya. EC Microbiol. 2015;1(1):23–32.

Abujnah AA, Zorgani A, Sabri MA, El-Mohammady H, Khalek RA, Ghenghesh KS. Multidrug resistance and extended-spectrum β-lactamases genes among0 Escherichia coli from patients with urinary tract infections in Northwestern Libya. L J M. 2015;10(1). DOI: https://doi.org/10.3402/ljm.v10.26412

Shallouf, M., Abrantes, P.M. Fielding, B and Africa CW. Colistin, Carbapenem and Cephalosporin-resistant Klebsiella pneumoniae reported from Misrata, Libya. S Afr J Infect Dis. 2017;32 (Supple:85).

Ahmad KM, Alamen AA, Shamsi SA, Elzen AA. Co-expression of Extended Spectrum βlactamase (ESBL) and AmpC β-lactamase among Pseudomonas aeruginosa clinical isolates in sebha medical center.J Appl Pure Sci Agric. 2019; 18(1):1-6.

Abdel-Moaty MM, Mohamed WS, Abdel-All SM, El-Hendawy HH. Prevalence and molecular epidemiology of extended spectrum β-lactamase producing Escherichia coli from hospital and community settings in Egypt. J App Pharm Sci, 2016; 6 (01): 042- 047. DOI: https://doi.org/10.7324/JAPS.2016.600107

Fam NS, Defasque S, Bert F. Faecal carriage of extended-spectrum β -lactamase (ESBL)-producing enterobacteria in liver disease patients from two hospitals in Egypt and France : a comparative epidemiological study.Infect Epidemiol Microbiol 2015; 143:1247–1255. DOI: https://doi.org/10.1017/S0950268814001812

Khater ES, Sherif HW. Rapid Detection of Extended Spectrum Β-lactamase (ESBL) Producing Strain of Escherichia coli in Urinary Tract Infections Patients in Benha University Hospital, Egypt. Br Microbiol Res J. 2014;4(4):443–53. DOI: https://doi.org/10.9734/BMRJ/2014/7376

Noha AH, Ahmed SK, Eman MF, Adel MH, Medhat AF. Molecular characterization of extended-spectrum β lactamase-producing E.colirecovered from community- acquired urinary tract infections in Upper Egypt. Sci Rep. 2020;10:2772. DOI: https://doi.org/10.1038/s41598-020-59772-z

Moges F, Eshetie S, Abebe W, Mekonnen F, Dagnew M, Endale A, etal. High prevalence of extended-spectrum beta-lactamase-producing Gram-negative pathogens from patients attending Felege Hiwot Comprehensive Specialized Hospital, Bahir Dar, Amhara region. PloS one. 2019;14(4): 1-13. DOI: https://doi.org/10.1371/journal.pone.0215177

Moremi N, Silago V, Mselewa EG, Chifwaguzi AP, Mirambo MM, Mushi MF, et al. Extended-spectrum β-lactamase blaCTX-M-1 group in gram-negative bacteria colonizing patients admitted at Mazimbu hospital and Morogoro Regional hospital in Morogoro, Tanzania. BMC Res Notes. 2021;14(1):1-7. DOI: https://doi.org/10.1186/s13104-021-05495-x

Marando R, Seni J, Mirambo MM, Falgenhauer L, Moremi N, Mushi MF, et al. Predictors of the extended-spectrum-beta lactamases producing Enterobacteriaceae neonatal sepsis at a tertiary hospital, Tanzania. Int J Med Microbiol. 2018;308(7):803-11. DOI: https://doi.org/10.1016/j.ijmm.2018.06.012

El-Kersh TA, Marie MA, Al-Sheikh YA, Al-Kahtani SA. Prevalence and risk factors of community-acquired urinary tract infections due to ESBL-producing Gram negative bacteria in an Armed Forces Hospital in Sothern Saudi Arabia. Glo. Adv. Res. J. Med. Med. Sci. 2015;4(7):321-30.

Aldrazi FA, Rabaan AA, Alsuliman SA, Aldrazi HA, Alabdalslam MJ, Alsadiq SA, et al. ESBL expression and antibiotic resistance patterns in a hospital in Saudi Arabia: Do healthcare staff have the whole picture?J Infect Public Health. 2020;13(5):759-66. DOI: https://doi.org/10.1016/j.jiph.2019.12.001

Alyamani EJ, Khiyami AM, Booq RY, Majrashi MA, Bahwerth FS, Rechkina E. The occurrence of ESBL-producing Escherichia coli carrying aminoglycoside resistance genes in urinary tract infections in Saudi Arabia. Ann Clin Microbiol Antimicrob. 2017;16(1):1-3. DOI: https://doi.org/10.1186/s12941-016-0177-6

Taha SA, Omar HH. Characterization of plasmid-mediated qnrA and qnrB genes among Enterobacteriaceae strains: quinolone resistance and ESBL production in Ismailia, Egypt. Egypt J Med Hum Genet 2019;20(1):1-7. DOI: https://doi.org/10.1186/s43042-019-0026-1

Mohamed ES, Khairy RM, Abdelrahim SS. Prevalence and molecular characteristics of ESBL and AmpC β-lactamase producing Enterobacteriaceae strains isolated from UTIs in Egypt. Antimicrob Resist Infect Control 2020;9(1):1-9. DOI: https://doi.org/10.1186/s13756-020-00856-w

Clinical and Laboratory Standards Institute. CLSI. Performance Standards for Antimicrobial Susceptibility Testing. CLSI supplement M100. 32nd ed. 2022.

Osthoff M, McGuinness SL, Wagen AZ, Eisen DP. Urinary tract infections due to extended-spectrum beta-lactamase-producing Gram-negative bacteria: identification of risk factors and outcome predictors in an Austral.